2023年6月5日,Avadel制药宣布LUMRYZ现已上市。LUMRYZ是一种羟丁酸钠缓释口服混悬剂,睡前服用一次,用于治疗发作性睡病成人患者的猝倒或白天过度嗜睡(EDS)。原文:
网页链接查看全文
产业链观察2023-03-30 16:25
#药闻简讯# 2023 年 3 月 29 日,专注于通过药物改造来改变生活的生物制药公司$Avadel制药(AVDL)$ 今天宣布与 RTW Investments, LP 及其某些附属公司签订特许权使用费协议高达 7500 万美元,以支持 LUMRYZ ™的潜在商业化,用于治疗发作性睡病成人的猝倒症或白天过度嗜睡( EDS )。 同时,该公...查看全文
美股滚雪球2023-02-27 09:37
$Avadel制药(AVDL)$ 寻求FDA对其睡眠障碍疗法Lumryz的最终批准,因为$爵士制药(JAZZ)$ 因专利纠纷败诉。
FDA已经初步批准Lumryz治疗成人嗜睡症患者的过度白天嗜睡(EDS)或猝倒。
然而,Jazz(Jazz)根据美国专利第8731963号(REMS专利)对Lumryz的知识产权提出了异议,该专利在FDA的橙皮...查看全文
牛唐2022-05-31 22:05
医药板块速评(2022.05.30)
本期内容提示:
1、市值低于现金,机构多次加仓的烟蒂股是否会迎来反弹机会?
2、嗜睡症药物公司$Avadel制药(AVDL)$ 期权活跃,后续走势如何看?
3、$天境生物(IMAB)$ 暴跌,是否有抄底机会?
$百济神州-U(SH688235)$查看全文
chuminhua2022-05-27 14:29
5月26日,Avadel Pharmaceuticals 股价周四下跌多达 63%,此前该公司披露专利问题可能会将 FDA 对其在研嗜睡症治疗药物 FT218 的批准推迟到 2023 年 6 月。该药为每晚一次的羟丁酸钠制剂,用于嗜睡症成人患者白天过度嗜睡和猝倒。
然而,在一份美国证券文件中,Avadel 表示,FDA 通知它与 FT21...查看全文
$Avadel Pharmaceuticals plc American Depositary Shares(AVDL)$ 8-K - Current report Filed: 2017-01-05 AccNo: 0001144204-17-000904 Size: 29 KBItem 3.03: Material Modifications to Rights of Security HoldersItem 5.01: Changes in Control of RegistrantItem 9.01: Financial Statement...
$Avadel Pharmaceuticals plc American Depositary Shares(AVDL)$ 8-K - Current report Filed: 2017-01-06 AccNo: 0001012477-17-000002 Size: 64 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Avadel Pharmaceuticals plc American Depositary Shares(AVDL)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-01-06 AccNo: 0000919574-17-000144 Size: 119 KB 网页链接
$Avadel Pharmaceuticals plc American Depositary Shares(AVDL)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2017-01-06 AccNo: 0000919574-17-000142 Size: 119 KB 网页链接
$Avadel Pharmaceuticals plc American Depositary Shares(AVDL)$ 8-K12B - Notification that a class of securities of successor issuer is deemed to be registered pursuant to section 12(b) Filed: 2017-01-04 AccNo: 0001144204-17-000636 Size: 368 KBItem 1.01: Entry into a Material D...
$Avadel Pharmaceuticals plc American Depositary Shares(AVDL)$ 8-K - Current report Filed: 2017-01-04 AccNo: 0000910680-17-000006 Size: 45 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Avadel Pharmaceuticals plc American Depositary Shares(AVDL)$ 25-NSE/A [Amend] - Notification filed by national security exchange to report the removal from listing and registration of matu Filed: 2017-01-04 AccNo: 0001354457-17-000004 Size: 3 KB 网页链接
$Avadel Pharmaceuticals plc American Depositary Shares(AVDL)$ 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redee Filed: 2017-01-04 AccNo: 0001354457-17-000001 Size: 2 KB 网页链接
$Avadel Pharmaceuticals plc American Depositary Shares(AVDL)$ 15-12G - Securities registration termination [Section 12(g)] Filed: 2017-01-03 AccNo: 0000910680-17-000002 Size: 10 KB 网页链接